🚨 ‘Impossible’: FDA’s Fast Review of Pfizer Vaccine Sparks Debate on Thoroughness
“The only way the FDA could have finished a full analysis of Pfizer’s IPD in 22 days is if they cut corners or they only analysed the aggregated information submitted in the dossier.” — Peter Gøtzsche
⬇️
https://childrenshealthdefense.org/defender/fda-fast-review-pfizer-covid-vaccine/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20240625
Experts say that properly analyzing millions of pages of individual participant data would require at least six months, raising questions about the emergency authorization process used to get Pfizer’s COVID-19 shots to market.
childrenshealthdefense.org
0
Share on Telegram
Share on Facebook
Share on Twitter
Share on Reddit